St. Jude Children's Research Hospital is dedicated to improving the treatment of children with catastrophic illnesses, with a primary focus on cancer treatment and research. Investigators at St. Jude Children's Cancer Center are dedicated to the discovery of basic biological mechanisms in cancer pathogenesis and to improving the diagnosis and treatment for childhood cancers. Our scientists and physicians, whether engaged in discovery oriented, laboratory research or patient-focused clinical investigation, share a common dedication to improving the treatment and cure of children with cancer. Areas of strength in our Cancer Center include investigations of fundamental cell processes such as transcriptional regulation, cell signal transduction, and cell cycle control, elucidation of molecular mechanisms of oncogenesis including chromosomal translocations and tumor suppressor gene inactivation, molecular analysis of drug action, evaluation of innovative treatment strategies and the development of new therapeutic modalities. Hallmarks of our multidisciplinary research programs include a strong foundation of discovery-oriented, investigator-initiated research, and successful interactions among basic scientists and clinical investigators to translate new findings into innovative treatments to improve the outcomes of children with cancer. St. Jude Children's Cancer Center comprises six established programs (Signal Transduction, Hematological Malignancies, Molecular Oncogenesis, Solid Malignancies, Transplantation and Gene Therapy, and Viral Oncogenesis and Tumor Immunology) and two developing programs (Neurobiology and Brain Tumors, and Cancer Prevention and Control), supported by 18 Shared Resources that facilitate multidisciplinary research among our 141 Cancer Center members. As the only NCI-sponsored Cancer Center devoted solely to cancer in children, St. Jude is uniquely positioned to integrate basic and clinical research to elucidate the mechanisms and improve the treatment of childhood cancers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA021765-21S1
Application #
2867371
Study Section
Subcommittee G - Education (NCI)
Project Start
1977-09-01
Project End
2002-02-28
Budget Start
1998-03-18
Budget End
1999-02-28
Support Year
21
Fiscal Year
1998
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Hatfield, M Jason; Binder, Randall J; Gannon, Rowan et al. (2018) Potent, Irreversible Inhibition of Human Carboxylesterases by Tanshinone Anhydrides Isolated from Salvia miltiorrhiza (""Danshen""). J Nat Prod 81:2410-2418
Vo, BaoHan T; Kwon, Jin Ah; Li, Chunliang et al. (2018) Mouse medulloblastoma driven by CRISPR activation of cellular Myc. Sci Rep 8:8733
Shadrick, William R; Slavish, Peter J; Chai, Sergio C et al. (2018) Exploiting a water network to achieve enthalpy-driven, bromodomain-selective BET inhibitors. Bioorg Med Chem 26:25-36
Ramsey, Laura B; Balis, Frank M; O'Brien, Maureen M et al. (2018) Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance. Oncologist 23:52-61
Churchman, Michelle L; Qian, Maoxiang; Te Kronnie, Geertruy et al. (2018) Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia. Cancer Cell 33:937-948.e8
Huang, I-Chan; Brinkman, Tara M; Mullins, Larry et al. (2018) Child symptoms, parent behaviors, and family strain in long-term survivors of childhood acute lymphoblastic leukemia. Psychooncology 27:2031-2038
Huang, I-Chan; Klosky, James L; Young, Chelsea M et al. (2018) Misclassification of self-reported smoking in adult survivors of childhood cancer. Pediatr Blood Cancer 65:e27240
Mandrell, Belinda N; Avent, Yvonne; Walker, Breya et al. (2018) In-home salivary melatonin collection: Methodology for children and adolescents. Dev Psychobiol 60:118-122
Drummond, Catherine J; Hanna, Jason A; Garcia, Matthew R et al. (2018) Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors. Cancer Cell 33:108-124.e5
Jones, Conor M; Baker, Justin N; Keesey, Rachel M et al. (2018) Importance ratings on patient-reported outcome items for survivorship care: comparison between pediatric cancer survivors, parents, and clinicians. Qual Life Res 27:1877-1884

Showing the most recent 10 out of 6764 publications